Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
259
-
Total 13F shares, excl. options
-
42.5M
-
Shares change
-
-1.17M
-
Total reported value, excl. options
-
$11.6B
-
Value change
-
-$301M
-
Put/Call ratio
-
1.02
-
Number of buys
-
144
-
Number of sells
-
-100
-
Price
-
$272.17
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q1 2025
301 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q1 2025.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 259 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.5M shares
of 1.39B outstanding shares and own 3.07% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (8.8M shares), Capital International Investors (5.09M shares), PRIMECAP MANAGEMENT CO/CA/ (5.06M shares), BAILLIE GIFFORD & CO (3.63M shares), FMR LLC (3.45M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.71M shares), HHLR ADVISORS, LTD. (1.03M shares), Temasek Holdings (Private) Ltd (994K shares), CITADEL ADVISORS LLC (982K shares), and Paradigm Biocapital Advisors LP (666K shares).
This table shows the top 259 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.